Skip to main content
Ironwood Pharmaceuticals logo

Manager, R&D Business Partner (FP&A)

Ironwood Pharmaceuticals
August 20, 2026
Remote friendly (Boston, MA)
United States
Corporate Functions
Responsibilities:
- Serve as a strategic finance partner to global R&D, Quality, and Tech Ops teams, providing decision support, financial modeling, and insights to optimize resource allocation and drive strategic priorities.
- Lead end-to-end R&D financial planning and forecasting processes (AOP, quarterly forecasts, long-range plans), partnering with functional leaders to consolidate, prioritize, and assess investments.
- Own consolidated R&D financial reporting and performance management, including monthly close oversight, variance analysis, and preparation of executive-ready review materials.
- Manage financial oversight of R&D activities, including alliance support, complex long-term contracts (e.g., clinical trials, CROs, CMOs), and review of purchase requisitions and contracts to ensure proper accounting treatment.
- Ensure compliance with accounting standards and SOX requirements on accruals, reporting, and controls in partnership with Accounting teams.
- Drive continuous improvement of FP&A processes, systems, and reporting; establish best practices; deliver ad hoc analysis for corporate and cross-functional initiatives.

Requirements:
- Bachelor’s or equivalent degree required; concentration in a financial discipline and/or MBA preferred.
- 6+ years progressive financial reporting, planning, and analysis experience in pharma/biotech/health care; 3+ years supporting R&D organizations/teams.
- Strong facilitation, communication, and presentation skills; collaborative partnership with non-Finance personnel as a representative of Finance.
- Strong proficiency in Excel and PowerPoint required; experience with SAP and Adaptive or other financial consolidations systems strongly preferred.
- Strong understanding of systems, analytical tools, financial modeling, and data management.
- Strong understanding of GAAP and financial statement reporting preferred.